Concorde Asset Management’s First Trust Health Care AlphaDEX Fund FXH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-5,136
Closed -$313K 118
2016
Q3
$313K Buy
5,136
+1,604
+45% +$97.5K 0.39% 77
2016
Q2
$209K Sell
3,532
-1,768
-33% -$102K 0.21% 131
2016
Q1
$296K Sell
5,300
-1,233
-19% -$66.6K 0.34% 73
2015
Q4
$395K Sell
6,533
-1,265
-16% -$75.5K 0.44% 60
2015
Q3
$454K Buy
7,798
+31
+0.4% +$2.06K 0.77% 42
2015
Q2
$535K Buy
7,767
+1,690
+28% +$114K 0.68% 38
2015
Q1
$407K Buy
6,077
+709
+13% +$45.2K 0.46% 54
2014
Q4
$325K Buy
+5,368
New +$313K 0.41% 56

Other funds holding FXH

Concorde Asset Management's FXH Position: Q4 2016 in Review

Concorde Asset Management sold out of First Trust Health Care AlphaDEX Fund (FXH) in Q4 2016, closing a stake of 5,136 shares — an estimated $313K sold.

Concorde Asset Management first reported a position in FXH in Q4 2014 and held it in 8 quarters. The position peaked at $535K in Q2 2015. 116 funds tracked by Wall St. Rank hold FXH as of Q4 2016.

  • Concorde Asset Management reported no remaining First Trust Health Care AlphaDEX Fund position as of Q4 2016 after selling out during the quarter.
  • Concorde Asset Management sold 5,136 First Trust Health Care AlphaDEX Fund shares in Q4 2016, an estimated $313K.
  • Concorde Asset Management first reported a position in First Trust Health Care AlphaDEX Fund in Q4 2014 and held it in 8 quarters.
  • Concorde Asset Management's First Trust Health Care AlphaDEX Fund position peaked at $535K in Q2 2015.
  • 116 funds tracked by Wall St. Rank held First Trust Health Care AlphaDEX Fund as of Q4 2016.

Based on Concorde Asset Management's 13F filing for Q4 2016, filed 24 Jan 2017.